UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 54

Sortiert nach

Identification of Key Functional Genes and LncRNAs Influencing Muscle Growth and Development in Leizhou Black Goats

Genes, 2023-04, Vol.14 (4), p.881

2023

Volltextzugriff (PDF)

RNA-Seq Reveals miRNA and mRNA Co-regulate Muscle Differentiation in Fetal Leizhou Goats

Frontiers in veterinary science, 2022-03, Vol.9, p.829769-829769

2022

Volltextzugriff (PDF)

Surgery After Conversion Therapy With PD-1 Inhibitors Plus Tyrosine Kinase Inhibitors Are Effective and Safe for Advanced Hepatocellular Carcinoma: A Pilot Study of Ten Patients

Frontiers in oncology, 2021-10, Vol.11, p.747950-747950

2021

Volltextzugriff (PDF)

An Investigation of an Acute Gastroenteritis Outbreak: Cronobacter sakazakii , a Potential Cause of Food-Borne Illness

Frontiers in microbiology, 2018-10, Vol.9, p.2549-2549

2018

Volltextzugriff (PDF)

Causal relationship between Helicobacter pylori antibodies and gastroesophageal reflux disease (GERD): A mendelian study

PloS one, 2023-12, Vol.18 (12), p.e0294771-e0294771

2023

Volltextzugriff (PDF)

Defect Engineering of 2D Copper Tin Composite Nanosheets Realizing Promoted Electrosynthesis Performance of Hydrogen Peroxide

Small (Weinheim an der Bergstrasse, Germany), 2024-03, Vol.20 (11), p.e2306485-n/a

2024

Volltextzugriff (PDF)

Adaptive multinoulli-based Kalman filter with randomly unknown delayed and lost measurements

Digital signal processing, 2022-09, Vol.129, p.103653, Article 103653

2022

Volltextzugriff (PDF)

Banana Transcription Factor MaERF11 Recruits Histone Deacetylase MaHDA1 and Represses the Expression of MaACO1 and Expansins during Fruit Ripening

Plant physiology (Bethesda), 2016-06, Vol.171 (2), p.1070-1084

2016

Volltextzugriff (PDF)

Four cycles of R-CHOP followed by two applications of rituximab based on negative interim PET/CT: an analysis of a prospective trial

BMC cancer, 2022-04, Vol.22 (1), p.403-403, Article 403

2022

Volltextzugriff (PDF)

Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study

Journal of hematology and oncology, 2017-01, Vol.10 (1), p.22-8, Article 22

2017

Volltextzugriff (PDF)

Challenges and Solutions of the TFET Circuit Design

IEEE transactions on circuits and systems. I, Regular papers, 2020-12, Vol.67 (12), p.4918-4931

2020

Volltextzugriff (PDF)

Toward Efficient Object Detection in Aerial Images Using Extreme Scale Metric Learning

IEEE access, 2021, Vol.9, p.56214-56227

2021

Volltextzugriff (PDF)

Nanoarchitectonics of bamboo-based heterojunction photocatalyst for effective removal of organic pollutants

Chemical engineering journal (Lausanne, Switzerland : 1996), 2024-09, Vol.495, p.153431, Article 153431

2024

Volltextzugriff (PDF)

Causal relationship between Helicobacter pylori antibodies and gastroesophageal reflux disease

PloS one, 2023-12, Vol.18 (12), p.e0294771

2023

Volltextzugriff (PDF)

Safety, Tolerability, and Pharmacokinetics of Senaparib, a Novel PARP1/2 Inhibitor, in Chinese Patients With Advanced Solid Tumors: A Phase I Trial

The oncologist (Dayton, Ohio), 2023-12, Vol.28 (12), p.e1259-e1267

2023

Volltextzugriff (PDF)

Sugemalimab Monotherapy for Patients With Relapsed or Refractory Extranodal Natural Killer/T-Cell Lymphoma (GEMSTONE-201): Results From a Single-Arm, Multicenter, Phase II Study

Journal of clinical oncology, 2023-06, Vol.41 (16), p.3032-3041

2023

Volltextzugriff (PDF)

Deploying and Optimizing Convolutional Neural Networks on Heterogeneous Architecture

2019 IEEE 13th International Conference on ASIC (ASICON), 2019, p.1-4

2019

Volltextzugriff (PDF)

Clinical study of critical patients with hemorrhagic fever with renal syndrome complicated by acute respiratory distress syndrome

PloS one, 2014-02, Vol.9 (2), p.e89740-e89740

2014

Volltextzugriff (PDF)

First interim analysis of a phase 1 study of zanubrutinib (zanu) plus lenalidomide (len) in patients (pts) with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.7557-7557

2023

Volltextzugriff (PDF)

Lenvatinib plus anti-PD-1 antibodies as conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma: a single-arm, phase II trial

Journal for immunotherapy of cancer, 2023-09, Vol.11 (9), p.e007366

2023

Volltextzugriff (PDF)

Efficacy and safety of chiauranib in a combination therapy in platinum-resistant or refractory ovarian cancer: a multicenter, open-label, phase Ib and II study

Molecular cancer, 2024-08, Vol.23 (1), p.162

2024

Volltextzugriff (PDF)

Interim PET/CT result is the sole prognostic factor of survival in patients with advanced-stage diffuse large B-cell lymphoma: a subset analysis of a prospective trial

Journal of radioanalytical and nuclear chemistry, 2021, Vol.327 (1), p.353-358

2021

Volltextzugriff (PDF)

Preliminary Safety and Efficacy of Zanubrutinib in Combination with Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Blood, 2022-11, Vol.140 (Supplement 1), p.3750-3752

2022

Volltextzugriff (PDF)

GEMSTONE-201: Preplanned primary analysis of a multicenter, single-arm, phase 2 study of sugemalimab (suge) in patients (pts) with relapsed or refractory extranodal natural killer/T cell lymphoma (R/R ENKTL)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.7501-7501

2022

Volltextzugriff (PDF)

P1136: FIRST INTERIM ANALYSIS OF A PHASE 1 STUDY OF ZANUBRUTINIB PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA

HemaSphere, 2023-08, Vol.7 (S3), p.e1828304-n/a

2023

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(48)

Publikationsform

Sprache

Englisch
(51)
Chinesisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Life Sciences & Biomedicine
(20)
Humans
(15)
Oncology
(14)
Female
(8)
Adult
(7)
Technology
(7)
Analysis
(6)
Care And Treatment
(6)
Chemotherapy
(6)
Diffuse Large B-Cell Lymphoma
(6)
Health Aspects
(6)
Lymphoma
(6)
Male
(6)
Middle Aged
(6)
Aged
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)
Engineering
(5)
Lymphoma, Large B-Cell, Diffuse - Drug Therapy
(5)
Medical Research
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Identification of Key Functional Genes and LncRNAs Influencing Muscle Growth and Development in Leizhou Black Goats

RNA-Seq Reveals miRNA and mRNA Co-regulate Muscle Differentiation in Fetal Leizhou Goats

Surgery After Conversion Therapy With PD-1 Inhibitors Plus Tyrosine Kinase Inhibitors Are Effective and Safe for Advanced Hepatocellular Carcinoma: A Pilot Study of Ten Patients

An Investigation of an Acute Gastroenteritis Outbreak: Cronobacter sakazakii , a Potential Cause of Food-Borne Illness

Causal relationship between Helicobacter pylori antibodies and gastroesophageal reflux disease (GERD): A mendelian study

Defect Engineering of 2D Copper Tin Composite Nanosheets Realizing Promoted Electrosynthesis Performance of Hydrogen Peroxide

Adaptive multinoulli-based Kalman filter with randomly unknown delayed and lost measurements

Banana Transcription Factor MaERF11 Recruits Histone Deacetylase MaHDA1 and Represses the Expression of MaACO1 and Expansins during Fruit Ripening

Four cycles of R-CHOP followed by two applications of rituximab based on negative interim PET/CT: an analysis of a prospective trial

Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study

Challenges and Solutions of the TFET Circuit Design

Toward Efficient Object Detection in Aerial Images Using Extreme Scale Metric Learning

Nanoarchitectonics of bamboo-based heterojunction photocatalyst for effective removal of organic pollutants

Causal relationship between Helicobacter pylori antibodies and gastroesophageal reflux disease

Safety, Tolerability, and Pharmacokinetics of Senaparib, a Novel PARP1/2 Inhibitor, in Chinese Patients With Advanced Solid Tumors: A Phase I Trial

Sugemalimab Monotherapy for Patients With Relapsed or Refractory Extranodal Natural Killer/T-Cell Lymphoma (GEMSTONE-201): Results From a Single-Arm, Multicenter, Phase II Study

Deploying and Optimizing Convolutional Neural Networks on Heterogeneous Architecture

Clinical study of critical patients with hemorrhagic fever with renal syndrome complicated by acute respiratory distress syndrome

First interim analysis of a phase 1 study of zanubrutinib (zanu) plus lenalidomide (len) in patients (pts) with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL)

Lenvatinib plus anti-PD-1 antibodies as conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma: a single-arm, phase II trial

Efficacy and safety of chiauranib in a combination therapy in platinum-resistant or refractory ovarian cancer: a multicenter, open-label, phase Ib and II study

Interim PET/CT result is the sole prognostic factor of survival in patients with advanced-stage diffuse large B-cell lymphoma: a subset analysis of a prospective trial

Preliminary Safety and Efficacy of Zanubrutinib in Combination with Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

GEMSTONE-201: Preplanned primary analysis of a multicenter, single-arm, phase 2 study of sugemalimab (suge) in patients (pts) with relapsed or refractory extranodal natural killer/T cell lymphoma (R/R ENKTL)

P1136: FIRST INTERIM ANALYSIS OF A PHASE 1 STUDY OF ZANUBRUTINIB PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA

Suchergebnisse filtern